Box Office Roundup: ‘Venom: The Last Dance’ and Clint Eastwood’s ‘Juror No. 2’ Take on International Markets

This week, the box office witnessed some exciting developments. “Venom: The Last Dance” made headlines with impressive earnings, while Clint Eastwood’s latest film “Juror No. 2” had a more modest showing. These contrasting performances reveal the diverse preferences of moviegoers across the globe.

“Venom: The Last Dance” achieved a remarkable $317.1 million worldwide, firmly establishing itself in the international market. Remarkably, it crossed $300 million globally in just its second weekend. The film boasted $90 million from domestic viewers and $227 million from international audiences.

The success of “Venom: The Last Dance” can be attributed to its strong openings in key regions. In France, it debuted with $6.5 million, while Japan opened with $3.8 million. Additionally, big hits in China ($70.6 million) and Mexico ($13.4 million) greatly boosted its totals.

With a production budget of $120 million, this film is advantageous compared to many superhero movies that often exceed this cost. Despite not reaching the heights of its predecessors—2018’s “Venom”, which grossed $856 million, and 2021’s “Let There Be Carnage,” which earned $506 million—its current momentum suggests a solid performance in theaters for the weeks ahead.

On the other hand, Clint Eastwood’s “Juror No. 2” had a quieter debut, drawing in $5 million from 1,348 screens across six territories. According to Warner Bros., France took the lead with $3.1 million, followed by Spain at $937,000, and the U.K. with $442,000.

Although featuring talents like Nicholas Hoult and Toni Collette, the film's domestic gross remains undisclosed by Warner Bros. “Juror No. 2” centers around a juror caught in a moral dilemma during a high-profile murder trial. This intriguing premise has attracted attention but resulted in underwhelming box office figures.

Interestingly, despite receiving favorable reviews, the film's Oscar-qualifying run in the U.S. is limited. Sources suggest that Warner Bros. is opting against a full awards campaign for now. This decision allows the filmmakers to escape close examination regarding box office results, especially after Eastwood's previous film “Cry Macho” earned just $16.5 million globally.

As the box office results unfold, the contrasting performances of “Venom: The Last Dance” and “Juror No. 2” underscore the different reactions to superhero blockbusters and dramatic narratives. “Venom” demonstrates strong international appeal, while “Juror No. 2” is navigating a more cautious course.

Fans of comic adaptations can expect more thrills as “Venom” continues to screen, while those seeking compelling stories might still find something engaging in Eastwood’s latest project. The global box office landscape is dynamic, and it will be interesting to see how these films fare in the upcoming weeks.